Articles tagged with Neurochemistry
Markita del Carpio Landry, a young immigrant scientist, receives the Vilcek Prize for Creative Promise for her groundbreaking research on neurochemical communication and gene-editing technologies. Her work aims to address medicine's most compelling problems, including aberrations in neurotransmitter signaling.
Researchers at UT Health San Antonio discovered that norepinephrine release in the visual cortex is tied to processing of imagery and cells' activation. This local regulation enhances sensory-specific attention and may represent a mechanism to enhance focus.
Researchers discovered that a single protein, Kr-h1, responds to socially regulated hormones to orchestrate the complex social transition in Harpegnathos saltator ants. The study reveals important roles for gene regulation and hormone response in controlling animal brains' plasticity.
Researchers created the largest metabolome analysis of the mouse brain, revealing distinct chemical conversions between brain regions. Aging mice showed significant metabolic differences in brain sections, with lipids playing a crucial role in changes to brain function.
Researchers discovered a two-cell color detection system in lampreys, which they propose could be the evolutionary ancestor of single-cell systems in fish and reptiles. The study found that this ancient system produces similar responses to UV and visible light as modern single-cell systems.
Researchers at the University of Pittsburgh School of Medicine have found that brain tissue inflammation is a key driver of Alzheimer's disease progression. By targeting neuroinflammation, they believe combination therapy could be more effective in reducing amyloid plaque formation and limiting tau fiber spread.
Chronic light exposure disrupts circadian rhythms in rats, leading to memory deficits and amyloid β accumulation similar to Alzheimer's disease. Fluoxetine treatment prevents these effects, suggesting a potential therapeutic strategy.
Researchers at Niigata University have identified a key pathway involving the protein optineurin that may contribute to the development of amyotrophic lateral sclerosis (ALS) disease. The study found that optineurin inhibits the formation of stress-induced TDP-43 protein aggregates in motor neurons, which are a hallmark of ALS.
Tohoku University scientists created a miniaturized pH probe to investigate deep brain structures' chemical signals. The probe detects subtle pH fluctuations, which can reveal the influence of acidity on brain function and dysfunction in diseases like mental illness and seizures.
Cyanobacteria from Lake Okeechobee released toxins such as microcystin-LR, brevetoxin, and BMAA, potentially exposing coastal residents to adverse health effects. Chronic exposure to multiple toxins is a growing concern for human and animal health.
Researchers analyze dried cyanobacteria wafers from Lake Chad for toxins, finding safety concerns but also nutritional benefits. Dihe cakes are a rich source of dietary amino acids and may help undernourished villagers.
Researchers at Brain Chemistry Labs have developed a new blood test that can diagnose ALS earlier than current methods, using brain exosomes and microRNA. The test, based on genetic material shed by different tissues, distinguishes between ALS patients and healthy controls with high accuracy.
A new study published in the Journal of Neuropathology & Experimental Neurology suggests that amino acid L-serine may be useful in treating ALS. The study found that L-serine successfully reduced ALS-like changes in an animal model of ALS, including motor neuron degeneration and pro-inflammatory microglia.
Research aims to understand neurochemical basis of decision-making in organisms using limited resources. The project will investigate hormone changes in garter snakes during life phase transitions.
Researchers found evidence of neurochemical changes associated with lower neuronal health in brain regions formerly controlled by the missing hand. Despite recovered hand function, some changes may persist in individuals who receive hand transplants.
A Purdue University study found that mixing highly caffeinated energy drinks with alcohol can trigger changes in the adolescent brain similar to those seen with cocaine. The consequences last into adulthood, with exposed mice showing altered ability to deal with rewarding substances and increased risk of substance abuse.
Dr Matthew Baker has won an international award for his pioneering research on diagnosing brain tumours using vibrational spectroscopy. His work enables the development of accurate and efficient clinical diagnostics.
Researchers at Université Laval developed a new method to alleviate chronic pain by rekindling pain and then erasing it. By injecting capsaicin and administering a protein synthesis inhibitor, they induced temporary pain hypersensitivity, which was subsequently reversed.
Researchers from the University of Alaska Fairbanks are presenting their findings on stroke and Sudden Infant Death Syndrome (SIDS) at a conference in New York. The studies aim to understand the underlying causes of these conditions and explore potential new treatments for brain damage.
A new study by Weill Cornell Medical College found that young rats given Ritalin injections from week-old age showed significant brain changes linked to higher executive functioning and addiction. Changes resolved with time, but the findings suggest doctors must be careful in diagnosing ADHD before prescribing Ritalin.
Scientists have developed techniques to analyze the chemical composition of brain cells, enabling them to map the distribution of biologically important molecules like vitamin E. This breakthrough may lead to a better understanding of brain function in healthy and diseased brains.
Recent studies suggest that brain avalanches, triggered by neurochemicals, may be optimal for information storage. This discovery could lead to new treatments for memory disorders.
A new interdisciplinary brain research project has been launched at the University of Illinois, using a $1.5 million Keck Foundation grant to develop tools for understanding and correcting problems in brain circuitry. The goal is to identify natural chemical signatures to restore proper wiring and functioning in malfunctioning brains.
Dr. Paul D. Boyer, a long-time NIH grantee, has won the Nobel Prize in Chemistry for his groundbreaking work on ATP synthesis. His research has provided a deep understanding of the molecular mechanism by which ATP is formed, shedding light on fundamental processes in biology.